Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening

Emily A. Elstad, Anne Sutkowi-Hemstreet, Stacey L. Sheridan, Maihan Vu, Russell Harris, Valerie F. Reyna, Christine Marie Rini, Jo Anne Earp, Noel T. Brewer*

*Corresponding author for this work

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Background. Clinicians' perceptions of screening benefits and harms influence their recommendations, which in turn shape patients' screening decisions. We sought to understand clinicians' perceptions of the benefits and harms of cancer screening by comparing 2 screening tests that differ in their balance of potential benefits to harms: colonoscopy, which results in net benefit for many adults, and prostate-specific antigen (PSA) testing, which may do more harm than good. Methods. In this cross-sectional study, 126 clinicians at 24 family/internal medicine practices completed surveys in which they listed and rated the magnitude of colonoscopy and PSA testing benefits and harms for a hypothetical 70-year-old male patient and then estimated the likelihood that these tests would cause harm and lengthen the life of 100 similar men in the next 10 years. We tested the hypothesis that the availability heuristic would explain the association of screening test to perceived likelihood of benefit/harm and a competing hypothesis that clinicians' gist of screening tests as good or bad would mediate this association. Results. Clinicians perceived PSA testing to have a greater likelihood of harm and a lower likelihood of lengthening life relative to colonoscopy. Consistent with our gist hypothesis, these associations were mediated by clinicians' gist of screening (balance of perceived benefits to perceived harms). Limitations. Generalizability beyond academic clinicians remains to be established. Conclusions. Targeting clinicians' gist of screening, for example through graphical displays that allow clinicians to make gist-based relative magnitude comparisons, may influence their risk perception and possibly reduce overrecommendation of screening.

Original languageEnglish (US)
Pages (from-to)467-476
Number of pages10
JournalMedical Decision Making
Volume35
Issue number4
DOIs
StatePublished - May 10 2015

Keywords

  • PSA test
  • clinicians
  • colonoscopy
  • colorectal cancer screening
  • prostate cancer screening
  • risk perception

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening'. Together they form a unique fingerprint.

  • Cite this

    Elstad, E. A., Sutkowi-Hemstreet, A., Sheridan, S. L., Vu, M., Harris, R., Reyna, V. F., Rini, C. M., Earp, J. A., & Brewer, N. T. (2015). Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening. Medical Decision Making, 35(4), 467-476. https://doi.org/10.1177/0272989X15569780